Compare Chemcrux Enterp. with Similar Stocks
Stock DNA
Specialty Chemicals
INR 160 Cr (Micro Cap)
78.00
39
0.90%
0.24
2.45%
2.21
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Sep-17-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemcrux Enterprises Ltd Valuation Shifts Signal Price Attractiveness Challenges
Chemcrux Enterprises Ltd, a key player in the specialty chemicals sector, has seen a notable shift in its valuation parameters, moving from fair to expensive territory. This change, reflected in its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a reassessment of the stock’s price attractiveness amid sector peers and historical benchmarks.
Read full news article
Chemcrux Enterprises Ltd is Rated Sell
Chemcrux Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news articleAre Chemcrux Enterprises Ltd latest results good or bad?
Chemcrux Enterprises Ltd has reported its financial results for Q3 FY26, showcasing a notable sequential recovery in net profit and net sales. The company achieved a net profit of ₹1.58 crore, reflecting a significant quarter-on-quarter increase of 652.38% and a year-on-year growth of 19.70%. Net sales for the same quarter reached ₹22.11 crore, marking a 24.56% increase from the previous quarter and a 13.85% rise compared to the same period last year. This performance indicates a potential operational momentum, as the quarterly revenue is the highest recorded in at least eight quarters. However, it is essential to contextualize these results within the broader financial landscape of the company. The nine-month profit for FY26 stands at ₹1.88 crore, which represents a substantial decline of 49.33% year-on-year, highlighting ongoing challenges in profitability. The operating margin for Q3 FY26 was reported a...
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Feb-2026 | Source : BSENewspaper Publication of Unaudited Financial Results for the quarter and nine months ended 31st December 2025
Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2025
05-Feb-2026 | Source : BSEUnaudited Financial Results for the quarter and nine months ended 31st December 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 05Th February 2026
05-Feb-2026 | Source : BSEThe Board of Directors considered and approved Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2025 for F.Y. 2025-26 as reviewed and recommended by the Audit Committee along with Limited Review Report issued by Statutory Auditors of the Company Naresh & Co. Chartered Accountants.
Corporate Actions 
No Upcoming Board Meetings
Chemcrux Enterprises Ltd has declared 10% dividend, ex-date: 17 Sep 25
No Splits history available
Chemcrux Enterprises Ltd has announced 2:1 bonus issue, ex-date: 06 Sep 21
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Sanjay Marathe (36.46%)
Namita Bhandare (1.49%)
25.79%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 13.85% vs -10.96% in Dec 2024
YoY Growth in quarter ended Dec 2025 is 19.70% vs -50.38% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -1.75% vs -8.55% in Sep 2024
Growth in half year ended Sep 2025 is -87.03% vs -33.05% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 3.83% vs -9.43% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -49.06% vs -40.45% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -10.78% vs -17.53% in Mar 2024
YoY Growth in year ended Mar 2025 is -53.67% vs -41.23% in Mar 2024






